Named as a key player in 66 of our reports, across 33 regions and countries.
[1] ClinicalTrials.gov, Studies led by Oxford Biomedica or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Our reports that name Oxford Biomedica as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Oxford Biomedica (number of shared markets).
Charles River Laboratories2 shared markets
Lonza Ltd2 shared markets
Thermo Fisher Scientific Inc.2 shared markets
Catalent1 shared market
Takara Bio1 shared market
WuXi AppTec1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
1 active study led by Oxford Biomedica, of 7 in all
Source: ClinicalTrials.gov, Studies with Oxford Biomedica (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
The topics of the markets Oxford Biomedica is in.